SCHEMBL3020150

SCHEMBL3020150

CCOC(=O)OCCCOC(=O)O

nearest known ligand 0.59

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.59
SOAT1 P35610 1/20 0.48
LMNA P02545 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ALOX15 P16050 1/20 0.37
MGAM O43451 1/20 0.37
GAA P10253 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
CYP2D6 P10635 1/20 0.36
HCAR2 Q8TDS4 4/20 0.35
ATM Q13315 1/20 0.35
TRPA1 O75762 1/20 0.34
NAAA Q02083 1/20 0.34
CYP1A2 P05177 1/20 0.34
THRB P10828 1/20 0.33
PKM P14618 1/20 0.33
HPGD P15428 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14781523 0.91 ALDH1A1 (0.65) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL7197469 0.91 ALDH1A1 (0.72) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL138615 0.88 ALDH1A1 (0.68) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL10344245 0.85 ALDH1A1 (0.72) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL3110838 0.84 ALDH1A1 (0.56) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL28625839 0.84 ALDH1A1 (0.52) ALDH1A1SOAT1LMNACYP2D6HCAR2
SCHEMBL4344436 0.84 ALDH1A1 (0.62) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL6940068 0.83 ALDH1A1 (0.68) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL26606238 0.83 ALDH1A1 (0.77) ALDH1A1SOAT1LMNAHSD17B10ALOX15
SCHEMBL1469388 0.82 ALDH1A1 (0.59) ALDH1A1SOAT1LMNAHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11923541-B2 Lithium ion secondary battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2024-03-05 US disclosed
US-11387052-B2 Nonaqueous lithium-type power storage element ASAHI KASEI KABUSHIKI KAISHA (JP) 2022-07-12 US disclosed
CN-111415821-B Method for manufacturing nonaqueous lithium storage device 旭化成株式会社 2022-06-07 CN disclosed
US-8334301-B2 5-Membered heterocyclic compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-12-18 US disclosed
US-20100210696-A1 5-MEMBERED HETEROCYCLIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-08-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100210696-A1 5-MEMBERED HETEROCYCLIC COMPOUND NPY4R, NPY5R, NPY1R ALDH1A1 2505/4885SOAT1 1555/4885LMNA 3785/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.